GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-38 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹255 Cr |
| Mar2021 | ₹14 Cr |
How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-38 Cr | Negative | |
| Mar2024 | ₹389 Cr | 1,902.17 | |
| Mar2023 | ₹19 Cr | -92.37 | |
| Mar2022 | ₹255 Cr | 1,695.19 | |
| Mar2021 | ₹14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,251.5 Cr | -0.5% | 5.3% | 43.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.5% |
5.3% |
43.5% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses